Our research provides new directions and insights into the mechanism of ITGA3 in breast cancer and determined that ITGA3 may be a potential prognostic-related biomarker in BRCA, offering new ideas for clinical diagnosis and application. Here, ITGA3 is linked to breast carcinoma.